BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20185367)

  • 21. Cardiac
    Gupta A
    Heart Fail Rev; 2023 Mar; 28(2):485-532. PubMed ID: 36427161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principals and clinical applications of magnetic resonance cardiac spectroscopy in heart failure.
    Qureshi WT; Nasir UB
    Heart Fail Rev; 2017 Jul; 22(4):491-499. PubMed ID: 28386690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the theoretical limits of detecting cyclic changes in cardiac high-energy phosphates and creatine kinase reaction kinetics using in vivo ³¹P MRS.
    Weiss K; Bottomley PA; Weiss RG
    NMR Biomed; 2015 Jun; 28(6):694-705. PubMed ID: 25914379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.
    Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD
    Liver Int; 2005 Apr; 25(2):273-81. PubMed ID: 15780050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of magnetic resonance spectroscopy in cardiology. State of the art].
    Walecki J; Michalak MJ; Michalak E; Pasowicz M
    Przegl Lek; 2002; 59(8):601-5. PubMed ID: 12638329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Cardiac Metabolism by Magnetic Resonance Spectroscopy in Heart Failure.
    Dellegrottaglie S; Scatteia A; Pascale CE; Renga F; Perrone-Filardi P
    Heart Fail Clin; 2019 Jul; 15(3):421-433. PubMed ID: 31079700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiac imaging by nuclear magnetic resonance. II. Spectroscopy].
    Lanzer PA
    Z Kardiol; 1986 Aug; 75(8):449-62. PubMed ID: 3535275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial lipid content in Fabry disease: a combined
    Petritsch B; Köstler H; Weng AM; Horn M; Gassenmaier T; Kunz AS; Weidemann F; Wanner C; Bley TA; Beer M
    BMC Cardiovasc Disord; 2016 Oct; 16(1):205. PubMed ID: 27793097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myocardial lipids and creatine measured by magnetic resonance spectroscopy among patients with heart failure].
    Winter JL; Castro P; Meneses L; Chalhub M; Verdejo H; Greig D; Gabrielli L; Chiong M; Concepción R; Mellado R; Hernández C; Uribe S; Lavandero S
    Rev Med Chil; 2010 Dec; 138(12):1475-9. PubMed ID: 21526294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy.
    Beer M; Wagner D; Myers J; Sandstede J; Köstler H; Hahn D; Neubauer S; Dubach P
    J Am Coll Cardiol; 2008 May; 51(19):1883-91. PubMed ID: 18466804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vivo
    Valkovič L; Chmelík M; Krššák M
    Anal Biochem; 2017 Jul; 529():193-215. PubMed ID: 28119063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy.
    Nakae I; Mitsunami K; Matsuo S; Inubushi T; Morikawa S; Tsutamoto T; Koh T; Horie M
    Circ J; 2005 Jun; 69(6):711-6. PubMed ID: 15914951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Magnetic resonance tomography of the heart].
    Smith HJ
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1337-41. PubMed ID: 10868098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac
    Gupta A; Houston B
    Heart Fail Rev; 2021 Jul; 26(4):839-859. PubMed ID: 33409666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Cardiac
    Bakermans AJ; Bazil JN; Nederveen AJ; Strijkers GJ; Boekholdt SM; Beard DA; Jeneson JAL
    Front Physiol; 2017; 8():939. PubMed ID: 29230178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging and spectroscopy of the heart.
    de Roos A; van der Wall EE
    Curr Opin Cardiol; 1991 Dec; 6(6):946-52. PubMed ID: 10149602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of Myocardial Creatine and Triglyceride Content in the Human Heart: Precision and Accuracy of in vivo Proton Magnetic Resonance Spectroscopy.
    Bakermans AJ; Boekholdt SM; de Vries DK; Reckman YJ; Farag ES; de Heer P; Uthman L; Denis SW; Zuurbier CJ; Houtkooper RH; Koolbergen DR; Kluin J; Planken RN; Lamb HJ; Webb AG; Strijkers GJ; Beard DA; Jeneson JAL; Nederveen AJ
    J Magn Reson Imaging; 2021 Aug; 54(2):411-420. PubMed ID: 33569824
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Secchi F; Di Leo G; Petrini M; Spairani R; Alì M; Guazzi M; Sardanelli F
    Radiol Med; 2017 Apr; 122(4):265-272. PubMed ID: 28070839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of myocardial creatine concentration in dysfunctional human heart by proton magnetic resonance spectroscopy.
    Nakae I; Mitsunami K; Matsuo S; Matsumoto T; Morikawa S; Inubushi T; Koh T; Horie M
    Magn Reson Med Sci; 2004 Apr; 3(1):19-25. PubMed ID: 16093616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [31P-cardio-MR-spectroscopy in myocardial insufficiency].
    Krahe T; Schindler R; Neubauer S; Ertl G; Horn M; Lackner K
    Rofo; 1993 Jul; 159(1):64-70. PubMed ID: 8334261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.